Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genprex, Inc.GNPX · Entity 8441 | President & COO | January 25, 2019 | January 29, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genprex, Inc.
Report date January 25, 2019 · Filed January 29, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.62 · Expires 2029-01-25 | Direct | 432,692 |
Reported balance
After 2019-01-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-25 · Grant · Acquired 432,692 · Balance 432,692 F1: One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of January 25, 2019 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of January 25, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of January 25, 2019 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of January 25, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2019 Filed Jan 29, 2019 19:44 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (Right to Buy) · Derivative | 432,692 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-19-005726 · doc4.xml · derivative · entry 1 Pham Julien L · CIK 0001735525 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,692 Underlying: Common Stock · 432,692 shares Expires 2029-01-25 F1 · derivative.exercise_date: One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of January 25, 2019 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of January 25, 2019. Read SEC document |
| July 30, 2018 Filed Aug 2, 2018 20:59 UTC | Genprex, Inc. GNPX · Entity 8441 | PurchaseCommon Stock | 500 | $3.40 | $1,700.00 |
DisclosureSEC source: 0001185185-18-001335 · ownership.xml · nonDerivative · entry 1 Pham Julien L · CIK 0001735525 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:38 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock option (right to buy) · Derivative | 659,346 | $0.00 Strike: $9.80 | $0.00 |
DisclosureSEC source: 0001185185-18-001002 · form4-pham052518.xml · derivative · entry 1 Pham Julien L · CIK 0001735525 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,346 Underlying: Common Stock · 659,346 shares Expires 2028-05-23 F1 · derivative.exercise_date: 1/2 of the shares vest as follows: 1/3 of such shares vest one year after 5/23/2018; the remaining 2/3 of such shares vest in equal quarterly installments over the following 2 years. The other 1/2 of the shares vest on achievement of performance goals. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.